Wugen

WUGEN Inc. is a biotechnology company developing a novel CAR-T therapy platform for fratricide-resistant CAR-T cell therapy for T-cell malignancies.

biotechnology

St. Louis United States

4340 Duncan Ave

http://www.wugen.com

Last Updated : on 2021-06-01


Ayman Kabakibi
Chief Operating Officer
Wugen
Biotechnology
United States
San Diego
Dan Kemp
President & CEO
Wugen
Biotechnology
United States
Middletown
Matthew Cooper
Chief Scientific Officer and Co-Founder
Wugen
Biotechnology
United States
Saint Louis